Ginkgo Bioworks Posts $27.7 Million in Q3 Revenue, Reaffirms 2026 Cash-Burn Outlook

The company recorded a $0.64 GAAP loss per share, $0.22 better than estimates, while revenue exceeded estimates by $6.19 million.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.